Congenital factor XIII deficiency: comprehensive overview of the FranceCoag cohort.
Séverine BouttefroySandrine MeunierVanessa MilienMohamed BoucekinePierre ChamouniDominique DesprezAnnie HarrocheAudrey HochartMarie Françoise Thiercelin-LegrandBénédicte WibautHervé ChambostLucia Rugerinull nullPublished in: British journal of haematology (2019)
This FranceCoag network study assessed 33 patients with congenital factor XIII (FXIII) deficiency presenting FXIII levels <10 iu/dl. Diagnosis was based on abnormal bleeding in 29 patients, a positive family history in 2, recurrent miscarriages in 1 and was fortuitous in 1. Eighteen patients (62·1%) presented life-threatening umbilical or intracranial haemorrhages (ICH). Seven of the 15 patients who experienced ICH were diagnosed but untreated, including 3 with secondary neurological sequelae. All pregnancies without prophylaxis (26/26) led to miscarriages versus 3/16 with prophylaxis. In patients exhibiting FXIII levels <10 iu/dl, prophylaxis could be discussed at diagnosis and at pregnancy. Further controlled prospective studies are needed.